Log in to save to my catalogue

Cost-effectiveness analysis of lipegfilgrastim as primary prophylaxis in women with breast cancer in...

Cost-effectiveness analysis of lipegfilgrastim as primary prophylaxis in women with breast cancer in...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2045271510

Cost-effectiveness analysis of lipegfilgrastim as primary prophylaxis in women with breast cancer in Australia: a modelled economic evaluation

About this item

Full title

Cost-effectiveness analysis of lipegfilgrastim as primary prophylaxis in women with breast cancer in Australia: a modelled economic evaluation

Author / Creator

Publisher

Tokyo: Springer Japan

Journal title

Breast cancer (Tokyo, Japan), 2018-11, Vol.25 (6), p.671-680

Language

English

Formats

Publication information

Publisher

Tokyo: Springer Japan

More information

Scope and Contents

Contents

Objectives
To examine the cost-effectiveness of lipegfilgrastim versus pegfilgrastim as primary prophylaxis in women with early stage breast cancer.
Methods
Two Markov models including a chemotherapy and a post-chemotherapy models were constructed with a time horizon of 12 weeks and 30 years, respectively. All the transition probabilities...

Alternative Titles

Full title

Cost-effectiveness analysis of lipegfilgrastim as primary prophylaxis in women with breast cancer in Australia: a modelled economic evaluation

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2045271510

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2045271510

Other Identifiers

ISSN

1340-6868

E-ISSN

1880-4233

DOI

10.1007/s12282-018-0872-6

How to access this item